• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hemostatic alterations in COVID-19.

作者信息

Peyvandi Flora, Artoni Andrea, Novembrino Cristina, Aliberti Stefano, Panigada Mauro, Boscarino Marco, Gualtierotti Roberta, Rossi Federica, Palla Roberta, Martinelli Ida, Grasselli Giacomo, Blasi Francesco, Tripodi Armando

机构信息

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UOC Pneumologia, Milan, Italy.

出版信息

Haematologica. 2021 May 1;106(5):1472-1475. doi: 10.3324/haematol.2020.262634.

DOI:10.3324/haematol.2020.262634
PMID:32855280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8094101/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8530/8094101/c1a4a7fa8869/1061472.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8530/8094101/6410e43d181e/1061472.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8530/8094101/c1a4a7fa8869/1061472.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8530/8094101/6410e43d181e/1061472.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8530/8094101/c1a4a7fa8869/1061472.fig2.jpg

相似文献

1
Hemostatic alterations in COVID-19.新型冠状病毒肺炎中的止血改变
Haematologica. 2021 May 1;106(5):1472-1475. doi: 10.3324/haematol.2020.262634.
2
COVID-19 and ECMO: An Unhappy Marriage of Endothelial Dysfunction and Hemostatic Derangements.新型冠状病毒肺炎与体外膜肺氧合：内皮功能障碍与止血紊乱的不良结合
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3193-3196. doi: 10.1053/j.jvca.2020.09.132. Epub 2020 Oct 2.
3
Emphasizing the Role of Endothelium-Related Hemostatic Factors in COVID-19 Sepsis.强调内皮相关止血因子在新型冠状病毒肺炎脓毒症中的作用
J Am Coll Surg. 2020 Dec;231(6):781-782. doi: 10.1016/j.jamcollsurg.2020.08.755. Epub 2020 Sep 18.
4
[Research study on nucleic acid testing of hemostatic stickers used and the surface of the recipients' hands after the inoculation of inactivated SARS-CoV-2 vaccine].[接种新型冠状病毒灭活疫苗后使用的止血贴及其接种者手部表面核酸检测的研究]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Mar 6;55(3):406-408. doi: 10.3760/cma.j.cn112150-20210205-00128.
5
Hemostatic abnormalities in COVID-19: A guided review.新型冠状病毒肺炎中的止血异常：一篇指导性综述。
An Acad Bras Cienc. 2020;92(4):e20200834. doi: 10.1590/0001-3765202020200834. Epub 2020 Aug 24.
6
The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations, and Treatment Recommendations.新型冠状病毒与止血异常：病理生理学、临床表现与治疗推荐。
Adv Exp Med Biol. 2021;1321:173-180. doi: 10.1007/978-3-030-59261-5_15.
7
[The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange].[欧亚治疗师协会关于新冠病毒感染途径的一些新机制的专家共识立场：聚焦止血、血液输血问题和血气交换]
Kardiologiia. 2020 May 4;60(5):9-19. doi: 10.18087/cardio.2020.5.n1132.
8
The evaluation of overall hemostatic potential assay in patients with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染患者整体止血潜力检测评估
Int J Lab Hematol. 2022 Oct;44(5):e219-e223. doi: 10.1111/ijlh.13881. Epub 2022 May 27.
9
Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score).根据止血异常（CAHA 评分）对 COVID-19 进行分期严重程度评估。
Thromb Haemost. 2020 Dec;120(12):1716-1719. doi: 10.1055/s-0040-1715836. Epub 2020 Aug 30.
10
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I.2019冠状病毒病（COVID-19）中的止血维持与血栓形成预防——第一部分
Semin Thromb Hemost. 2020 Oct;46(7):757-762. doi: 10.1055/s-0040-1717139. Epub 2020 Oct 20.

引用本文的文献

1
Coagulation Profile of Convalescent Plasma Donors and Recipients.康复期血浆捐献者和接受者的凝血指标
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251317522. doi: 10.1177/10760296251317522.
2
Correlating COVID-19 severity with biomarker profiles and patient prognosis.将 COVID-19 严重程度与生物标志物谱和患者预后相关联。
Sci Rep. 2024 Sep 27;14(1):22353. doi: 10.1038/s41598-024-71951-w.
3
The effect of SARS-CoV-2 on the incidence of post-operative venous sinus thrombosis following skull base procedures.SARS-CoV-2 对颅底手术后静脉窦血栓形成发生率的影响。

本文引用的文献

1
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.新型冠状病毒肺炎相关凝血病中的内皮病变：来自一项单中心横断面研究的证据
Lancet Haematol. 2020 Aug;7(8):e575-e582. doi: 10.1016/S2352-3026(20)30216-7. Epub 2020 Jun 30.
2
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血：SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
3
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
Acta Neurochir (Wien). 2024 Jul 22;166(1):302. doi: 10.1007/s00701-024-06197-6.
4
Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19.COVID-19 前两波的出血和血栓事件及肝素治疗强度。
Intern Emerg Med. 2024 Sep;19(6):1577-1583. doi: 10.1007/s11739-024-03635-2. Epub 2024 May 18.
5
No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2.接种新冠病毒疫苗的健康受试者的参数及凝血激活均无变化。
Thromb Update. 2021 Aug;4:100059. doi: 10.1016/j.tru.2021.100059. Epub 2021 Jun 25.
6
The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases.COVID-19 相关凝血病的管理：关注代谢和血管疾病的挑战。
Int J Mol Sci. 2023 Aug 14;24(16):12782. doi: 10.3390/ijms241612782.
7
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.米兰血栓性血小板减少性紫癜患者队列中接种SARS-CoV-2疫苗后的复发风险。
Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478.
8
Coagulation Profile of COVID-19 Patients.COVID-19患者的凝血指标
Life (Basel). 2022 Oct 20;12(10):1658. doi: 10.3390/life12101658.
9
Tissue factor in COVID-19-associated coagulopathy.COVID-19 相关凝血病中的组织因子。
Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025. Epub 2022 Oct 1.
10
Coronavirus Disease 2019-Associated Coagulopathy.2019冠状病毒病相关凝血病
Microorganisms. 2022 Aug 2;10(8):1556. doi: 10.3390/microorganisms10081556.
英国一家三级重症监护病房中，严重 COVID-19 患者的影像学证实的血栓栓塞事件。
Thromb Res. 2020 Sep;193:1-4. doi: 10.1016/j.thromres.2020.05.049. Epub 2020 May 29.
4
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
5
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?对于新冠肺炎患者的抗血栓预防，我们目前处于什么阶段？
Thromb Res. 2020 Jul;191:29. doi: 10.1016/j.thromres.2020.04.023. Epub 2020 Apr 20.
6
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
7
Type and dose of heparin in Covid-19: Reply.新冠病毒病中肝素的类型和剂量：回复
J Thromb Haemost. 2020 Aug;18(8):2063-2064. doi: 10.1111/jth.14870. Epub 2020 May 11.
8
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.